Alexander Traxl

411 total citations
17 papers, 326 citations indexed

About

Alexander Traxl is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Alexander Traxl has authored 17 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Pediatrics, Perinatology and Child Health and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Alexander Traxl's work include Drug Transport and Resistance Mechanisms (14 papers), Pharmacological Effects and Toxicity Studies (11 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Alexander Traxl is often cited by papers focused on Drug Transport and Resistance Mechanisms (14 papers), Pharmacological Effects and Toxicity Studies (11 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Alexander Traxl collaborates with scholars based in Austria, Germany and Norway. Alexander Traxl's co-authors include Oliver Langer, Thomas Wanek, Severin Mairinger, Johann Stanek, Michael Sauberer, Thomas Filip, Claudia Kuntner, Markus Müller, Martin Bauer and Nicolas Tournier and has published in prestigious journals such as Journal of Pharmaceutical Sciences, Clinical Pharmacology & Therapeutics and Journal of Nuclear Medicine.

In The Last Decade

Alexander Traxl

17 papers receiving 325 citations

Peers

Countries citing papers authored by Alexander Traxl

Since Specialization

Citations

This map shows the geographic impact of Alexander Traxl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Traxl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Traxl more than expected).

Fields of papers citing papers by Alexander Traxl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Traxl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Traxl. The network helps show where Alexander Traxl may publish in the future.

Co-authorship network of co-authors of Alexander Traxl

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Traxl. A scholar is included among the top collaborators of Alexander Traxl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Traxl. Alexander Traxl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Influence of ABC transporters on the excretion of ciprofloxacin assessed with PET imaging in mice 2021 ·European Journal of Pharmaceutical Sciences ·(unknown), Thomas Wanek, Michael Sauberer, Thomas Filip, Severin Mairinger, Johann Stanek, Alexander Traxl, Rudolf Karch, John D. Schuetz, Oliver Langer	10
2	Assessing the Functional Redundancy between P-gp and BCRP in Controlling the Brain Distribution and Biliary Excretion of Dual Substrates with PET Imaging in Mice 2021 ·Pharmaceutics ·(unknown), Severin Mairinger, Alexander Traxl, Michael Sauberer, Thomas Filip, Johann Stanek, Claudia Kuntner, Thomas Wanek, Oliver Langer	7
3	Reproducibility and Comparability of Preclinical PET Imaging Data: A Multicenter Small-Animal PET Study 2019 ·Journal of Nuclear Medicine ·Julia G. Mannheim, (unknown), Sybille Reder, Alexander Traxl, (unknown), Jonathan A. Disselhorst, (unknown), Claudia Kuntner, James T. Thackeray, Sibylle Ziegler, Thomas Wanek, Jens P. Bankstahl, Bernd J. Pichler	21
4	Measurement of Hepatic ABCB1 and ABCG2 Transport Activity with [¹¹C]Tariquidar and PET in Humans and Mice 2019 ·Molecular Pharmaceutics ·(unknown), Martin Bauer, Beatrix Wulkersdorfer, Alexander Traxl, C. Philippe, Maria Weber, Stéphanie Häusler, Bruno Stieger, Walter Jäger, Severin Mairinger, Thomas Wanek, Marcus Hacker, Markus Zeitlinger, Oliver Langer	19
5	Inhibition of ABCB1 and ABCG2 at the Mouse Blood–Brain Barrier with Marketed Drugs To Improve Brain Delivery of the Model ABCB1/ABCG2 Substrate [¹¹C]erlotinib 2019 ·Molecular Pharmaceutics ·Alexander Traxl, Severin Mairinger, Thomas Filip, Michael Sauberer, Johann Stanek, Stefan Poschner, Walter Jäger, (unknown), Gaia Novarino, Nicolas Tournier, Martin Bauer, Thomas Wanek, Oliver Langer	18
6	Influence of Multidrug Resistance-Associated Proteins on the Excretion of the ABCC1 Imaging Probe 6-Bromo-7-[11C]Methylpurine in Mice 2018 ·Molecular Imaging and Biology ·(unknown), Severin Mairinger, Markus Krohn, Thomas Wanek, Thomas Filip, Michael Sauberer, Johann Stanek, Alexander Traxl, John D. Schuetz, Claudia Kuntner, Jens Pahnke, Oliver Langer	17
7	Influence of breast cancer resistance protein and P-glycoprotein on tissue distribution and excretion of Ko143 assessed with PET imaging in mice 2018 ·European Journal of Pharmaceutical Sciences ·Severin Mairinger, (unknown), Thomas Wanek, Alexander Traxl, Thomas Filip, Michael Sauberer, Johann Stanek, Claudia Kuntner, Jens Pahnke, Markus Müller, Oliver Langer	3
8	Effect of Rifampicin on the Distribution of [¹¹C]Erlotinib to the Liver, a Translational PET Study in Humans and in Mice 2018 ·Molecular Pharmaceutics ·Martin Bauer, Alexander Traxl, Akihiro MATSUDA, Rudolf Karch, C. Philippe, Lukas Nics, Eva‐Maria Klebermass, Beatrix Wulkersdorfer, Maria Weber, Stefan Poschner, Nicolas Tournier, Walter Jäger, Wolfgang Wadsak, Marcus Hacker, Thomas Wanek, Markus Zeitlinger, Oliver Langer	16
9	Hepatocyte-Specific Deletion of EGFR in Mice Reduces Hepatic Abcg2 Transport Activity Measured by [11C]erlotinib and Positron Emission Tomography 2017 ·Drug Metabolism and Disposition ·Alexander Traxl, (unknown), Elisabeth Glitzner, Thomas Wanek, Severin Mairinger, Oliver Langer, Maria Sibilia	10
10	[ 11 C]Erlotinib PET cannot detect acquired erlotinib resistance in NSCLC tumor xenografts in mice 2017 ·Nuclear Medicine and Biology ·Alexander Traxl, (unknown), Thomas Wanek, Kushtrim Kryeziu, Christine Pirker, Severin Mairinger, Johann Stanek, Thomas Filip, Michael Sauberer, Claudia Kuntner, Walter Berger, Oliver Langer	6
11	A Prediction Method for P-glycoprotein–Mediated Drug–Drug Interactions at the Human Blood–Brain Barrier From Blood Concentration–Time Profiles, Validated With PET Data 2017 ·Journal of Pharmaceutical Sciences ·Akihiro MATSUDA, Rudolf Karch, Martin Bauer, Alexander Traxl, Markus Zeitlinger, Oliver Langer	3
12	Influence of OATPs on Hepatic Disposition of Erlotinib Measured With Positron Emission Tomography 2017 ·Clinical Pharmacology & Therapeutics ·Martin Bauer, Akihiro MATSUDA, Beatrix Wulkersdorfer, C. Philippe, Alexander Traxl, Csilla Özvegy‐Laczka, Johann Stanek, Lukas Nics, Eva‐Maria Klebermass, Stefan Poschner, Walter Jäger, (unknown), Éva Bakos, Gergely Szakács, Wolfgang Wadsak, Marcus Hacker, Markus Zeitlinger, Oliver Langer	47
13	Synthesis and preclinical characterization of 1-(6′-deoxy-6′-[18F]fluoro-β-d-allofuranosyl)-2-nitroimidazole (β-6′-[18F]FAZAL) as a positron emission tomography radiotracer to assess tumor hypoxia 2016 ·Bioorganic & Medicinal Chemistry ·Thomas Wanek, (unknown), (unknown), (unknown), Christoph Denk, Johann Stanek, Severin Mairinger, Thomas Filip, Michael Sauberer, (unknown), Alexander Traxl, (unknown), K. Mereiter, Friedrich Hammerschmidt, Carol E. Cass, Vijaya L. Damaraju, Oliver Langer, Claudia Kuntner	12
14	Strategies to Inhibit ABCB1- and ABCG2-Mediated Efflux Transport of Erlotinib at the Blood–Brain Barrier: A PET Study on Nonhuman Primates 2016 ·Journal of Nuclear Medicine ·Nicolas Tournier, Sébastien Goutal, Sylvain Auvity, Alexander Traxl, Severin Mairinger, Thomas Wanek, (unknown), Irène Buvat, Michaël Soussan, Fabien Caillé, Oliver Langer	46
15	Breast Cancer Resistance Protein and P-Glycoprotein Influence In Vivo Disposition of ¹¹C-Erlotinib 2015 ·Journal of Nuclear Medicine ·Alexander Traxl, Thomas Wanek, Severin Mairinger, Johann Stanek, Thomas Filip, Michael Sauberer, Markus Müller, Claudia Kuntner, Oliver Langer	49
16	[18F]FDG is not transported by P-glycoprotein and breast cancer resistance protein at the rodent blood–brain barrier 2015 ·Nuclear Medicine and Biology ·Thomas Wanek, Alexander Traxl, Jens P. Bankstahl, Marion Bankstahl, Michael Sauberer, Oliver Langer, Claudia Kuntner	2
17	Factors Governing P-Glycoprotein-Mediated Drug–Drug Interactions at the Blood–Brain Barrier Measured with Positron Emission Tomography 2015 ·Molecular Pharmaceutics ·Thomas Wanek, Kerstin Römermann, Severin Mairinger, Johann Stanek, Michael Sauberer, Thomas Filip, Alexander Traxl, Claudia Kuntner, Jens Pahnke, Florian F. Bauer, Thomas Erker, Wolfgang Löscher, Markus Müller, Oliver Langer	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact